Pyramid Pharma Services
Generated 5/9/2026
Executive Summary
Pyramid Pharma Services is a US-based Contract Development and Manufacturing Organization (CDMO) headquartered in San Diego, California, specializing in aseptic fill-finish and development services for injectable drugs. Founded in 2015, the company supports biologic, peptide, and small molecule programs from pre-clinical formulation through commercial manufacturing, offering formulation development, analytical testing, and sterile manufacturing into vials and syringes. As a private CDMO, Pyramid Pharma Services is well-positioned to capitalize on the growing demand for outsourced sterile injectable manufacturing, driven by the increasing complexity of biologics and the need for high-quality aseptic processing. The company's end-to-end service model and focus on quality and compliance make it a reliable partner for pharmaceutical sponsors seeking to accelerate drug development and commercialization timelines.
Upcoming Catalysts (preview)
- TBDCapacity expansion or new facility announcement50% success
- TBDStrategic partnership with a major pharmaceutical company40% success
- TBDClient product achieving FDA approval or key regulatory milestone60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)